BioAmber phases out E.coli use

The blog is just catching up with some of the earnings conference calls from last week. Here are some highlighted information from BioAmber. I am also checking out Codexis, Cereplast and Syntroleum if they have any interesting updates for the quarter.

An interesting information from BioAmber's recent earnings call is the phasing out its use of E.coli and has now switched to using yeast, which it has exclusively licensed from Cargill. BioAmber said it has successfully operated its yeast and purification process at large scale in the Pomacle, France, demonstration plant.

You can also read the blog's recent interview with BioAmber president Jean Francois Huc during the company's visit at the New York Stock Exchange (NYSE).

BioAmber currently produces it bio-succinic acid at a demo facility in Pomacle, France.

More on this post...